Ayd, F. J. (1961) A survey of drug-induced extra-pyramidal reactions. Journal of the American Medical Association, 175, 1054–1060.
Barnes, T. R. E.
Milavich, G., Curson, D. A. & Platt, S. D. (1983) Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic out-patients: pimozide versus fluphenazine. Social Psychiatry, 18, 193–199.
Bennett, D. H. (1978) Community Psychiatry. British Journal of Psychiatry, 132, 209.
Blackwell, B. & Shepherd, M. (1968) Prophylactic lithium: another therapeutic myth? Examination of evidence to date. Lawet
Bleuler, M. (1974) The long-term course of the schizophrenic psychoses. Psychological Medicine, 4, 244–254.
Brockingion, I. F., Kendell, R. E. & Leff, J. P. (1978) Definitions of schizophrenia: concordance and prediction of outcome. Psychological Medicine. 8, 387–398.
Capstick, N. (1980) Long-term Fluphenazine decanoate maintenance requirements of chronic schizophrenic patients. Acta psychiatrica scandinavica. 61, 256–262.
Carpenter, W. T., Bartko, J. J., Carpenter, C. L. & Strauss, J. L. (1976) Another view of schizophrenic sub-types. Archives of General Psychiatry. 33, 508–516.
Cheadle, A. J., Freeman, H. L. & Korer, J. (1978) Chronic schizophrenic patients in the community. British Journal of Psychiatry, 132, 221–227.
Cheadle, A. J. & Korer, J. R. (1979) A method for monitoring the care of schizophrenics in the community. British Journal of Psychiatry, 134, 412–418.
Cheung, H. K. (1981) Schizophrenics fully remitted on neuroleptics for 3–5 years – to stop or continue drugs?
British Journal of Psychiatry. 138, 490–494.
Cooper, J. E., Kendell, R. E., Gurland, B. J., Sharpe, L., Copeland, J. R. M. & Simon, R. (1972) Psychiatric Diagnosis in New York and London. London: Oxford University Press.
Crumpton, N. (1968) The role of drugs in maintaining patients in the community. In: Treatment of Mental Disorders in the Community. (ed. Daniel, G. R. & Freeman, H. L.). London: Bailliere Tindall.
Curson, D. A. (1980) Current trends in the medical treatment of schizophrenia. In: Current Trends in Treatment in Psychiatry, (ed. Tennent, T. G.). London: Pitman Medical.
Daniel, G. R. (1968) Social and economic effects of long-acting phenothiazines. British Journal of Social Psychiatry, 2, 167–169.
Davis, J. M. (1975) Overview: Maintenance therapy in psychiatry: I. Schizophrenia. American Journal of Psychiatry. 132, 1237–1245.
Davis, J. M. (1976) Recent developments in the drug treatment of schizophrenia. American Journal of Psychiatry, 133, 2, 208–214.
Dencker, S. J.
Leep, M. & Malm, U. (1980) Do schizophrenics well-adapted in the community need neuroleptics? A depot neuroleptic withdrawal study. Acta Psychiatrica Scandinavica
279, (suppl) 64–76.
Denham, J. & Adamson, L. (1971) The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta psychiatrica scandinavica, 47, 420.
Englehardt, D. M. & Freedman, N. (1970) Maintenance drug therapy: schizophrenic patients in the community. In Social Psychiatry Vol 1. Ed. Kiev, Avi. London: Routledgc & Kegan Paul.
Falloon, I., Watt, D. C. & Shepherd, M. (1978) A comparative trial of pimozide and fluphenazine decanoate in continuation therapy of schizophrenia. Psychological Medicine. 8, 59–70.
Forrest, A. D. & Hay, A. J. (1973) The Schizophrenias: operational definition. British Journal of Medical Psychology, 46, 337–346.
Freeman, H. L. (1983) Concepts of community psychiatry. British Journal of Hospital Medicine, 30, 2
Freeman, H. L.
Cheadle, A. J. & Korer, J. R. (1979) A method for monitoring the treatment of schizophrenia in the community. British Journal of Psychiatry, 134, 412–416.
Gardos, G. & Cole, J. O. (1976) Maintenance antipsychotic therapy: is the cure worse than the disease?
American Journal of Psychiatry, 133, 32–36.
Goldberg, D. (1974) Principles of rehabilitation. Comprehensive Psychiatry, 15, 237–248.
Hay, A. J. & Forrest, A. D. (1972) The diagnosis of schizophrenia and paranoid psychosis: an attempt at classification. British Journal of Medical Psychology, 45, 233–241.
Helmchen, H. & Hippius, H. (1967) Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt, 38, 445–461.
Hirsch, S. R. (1980) Current trends in the medical treatment of schizophrenia. In Current Trends in Treatment in Psychiatry (ed. Tennent, T. G.). London: Pitman Medical.
Hirsch, S. R.
Gaind, R., Rohde, P. D., Stevens, B. C. & Wing, J. K. (1973) Out-patient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind placebo trial. British Medical Journal, i, 633–637.
Hogarty, G., Goldberg, S., Schoder, N. & Ulrich, R. (1974) Drug and sociotherapy in the after-care of schizophrenic patients. II Two year relapse rates. Archives of General Psychiatry, 31, 603–609.
Ulrich, R. F., Mussare, F. & Aristigueta, N. (1976) Drug discontinuation among long-term successfully maintained schizophrenic outpatients. Diseases of the Nervous System, 57, 494–500.
Hollister, L. (1978) “Psychopharmacology”. In: Schizophrenia, Science and Practice. . (ed. Shershaw, J.). Cambridge, Mass: Harvard University Press.
Johnson, D. A. W. (1976) The expectation of outcome for maintenance therapy in chronic schizophrenia. British Journal of Psychiatry, 128, 246–250.
Johnson, D. A. W. (1978) Prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry, 132, 27–30.
Johnson, D. A. W. (1979a) Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. British Journal of Psychiatry, 135, 524–530.
Johnson, D. A. W. (1979b) Clinical considerations in the use of depot neuroleptics for the treatment of schizophrenia; In: Management of Schizophrenia: Biological and Sociological Aspects, (ed. Van Praag, H. M.). Assen: Van Gorcum.
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry, 139, 89–101.
Johnson, D. A. W. (1982) Haloperidol decanoate and the treatment of chronic schizophrenia. In Therapeutics Today Vol. 2. (ed. Johnson, D. A. W.). New York: Adis Press.
Johnson, D. A. W. & Freeman, H. L. (1972) The long-acting tranquillizers. Practitioner, 208, 395–402.
Johnson, D. A. W. (1973) Drug defaulting by patients on long-acting phenothiazines. Psychological Medicine, 3, 115–119.
Jus, A., Pineau, R., Lachance, R., Pelchat, G., Jus, K., Pirks, P. & Villeneuve, R. (1976) Epidemiology of tardive dyskinesia. Part 1
Diseases of the Nervous System, 37, 210–214.
Kane, J. M. (1981) Low dose neuroleptics in outpatient schizophrenics. In 3rd World Congress of Biological Psychiatry, , S181.
Kane, J. M.
Rikkin, A., Ouitkin, F., Nayak, D. & Saraf, K. (1979) Low dose fluphenazine decanoate in maintenance treatment of schizophrenia. Psychiatry Research, 1, 341–345.
Kennedy, P. F., Hershon, H. I. & McGuire, R. G. (1971) Extrapvramidal disorders after prolonged phenothiazine therapy. British Journal of Psychiatry, 118, 509–518.
Kidger, T., Barnes, T. R. E.
Trauer, T. & Taylor, P. J. (1980) Sub-syndromes of tardive dyskinesia. Psychological Medicine, 10, 513–520.
Knights, A., Okasha, M. S., Salih, M. A. & Hirsch, S. R. (1979) A trial of Fluphenazine versus flupenthixol in maintenance of schizophrenic outpatients. British Journal of Psychiatry, 135, 515–523.
Knights, A. & Hirsch, S. R. (1981) “Revealed” depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–811.
Kraepelin, E. (1919) “Dementia praecox and paraphrenia” (Trans R. M. Barclay from 8th Edition of “Psychiatrie“ Barth, Leipzig)
Leff, J. P. & Wing, J. K. (1971) Trial of maintenance therapy in schizophrenia. British Medical Journal, 3, 559–604.
Light, R. J. & Margolin, B. H. (1971) An analysis of variance for categorical data. Journal of the American Statistical Association, 66, 534–544.
Margolin, B. H. & Light, R.J. (1974) An analysis of variance for categorical data II. Journal of the American Statistical Association, 69, 755–764.
Markowe, M., Steinert, J. & Heyworth-Davis, F. (1967) Insulin and chlorpromazine in schizophrenia: A ten year comparative survey. British Journal of Psychiatry, 113, 1101–1106.
Mindham, R. I., Gaind, R. & Anstee, B. H. (1972) Comparison of orphenadrine and placebo on the control of phenothiazine-induced parkinsonism. Psychological Medicine, 2, 406–413.
Nie, N. H., Hull, C. H., Jenkins, J. G., Steinbrenner, K. & Bent, D. H. (1975) Statistical Package for the Social Sciences (SPSS)
New York: McGraw Hill.
Oldham, A. J. (1969) Community Psychiatry in London: A three year analysis. British Journal of Psychiatry, 115, 465.
Pasamanick, B., Scarpitti, F. R., Lefton, M., Dinitz, S., Wernert, J. J. & McPheeters, H. (1964) Home vs. hospital care for schizophrenics. Journal of the American Medical Association, 187, 177–181.
Platt, S., Weyman, A., Hirsch, S. R. & Hewett, S. (1980) The Social Behaviour assessment Schedule (SBAS): Rationale, Contents, scoring and reliability of a new interview schedule. Social Psychiatry, 15, 43–55.
Hirsch, S. & Weyman, A. (1983) Social Behaviour Assessment Schedule (SBAS)
Third Edition. Windsor: NFER-Nelson.
Rasmussen, O. S. (1970) Fluphenazine enanthate in sesame oil: a depot preparation. Acta Psychiatrica Scandinavica, 46, 311–357.
Rifkin, A., Ouiticin, F. & Klein, D. F. (1975) A poorly-recognised drug-induced extrapyramidal behavioural disorder. Archives of General Psychiatry, 32, 672–674.
Rifkin, A., Ouiticin, F. & Rabiner, C. J. (1977) Fluphenazine decanoate, fluphenazine hydrochloride, and placebo in remitted schziophrenics. Relapse rates after one year. Archives of General Psychiatry, 34, 43–47.
Shakow, D. (1977) On doing research in Schizophrenia. Psychological Issues, 10, 155–207.
Stevens, B. C. (1973) Role of Fluphenazine decanoate in lessening the burden of chronic schizophrenics in the community. Psychological Medicine, 3, 141–158.
Sturt, E., Wykes, T. & Creer, C. (1982) 1. Demographic, social, and clinical characteristics of the sample. In Psychological Medicine, Supplement 2.
Strauss, J. S. & Carpenter, W. T. (1972) The prediction of outcome in schizophrenia: characteristics of outcome. Archives of General Psychiatry, 27, 739–746.
Strauss, J. S. & Carpenter, W. T. (1974) Characteristic symptoms and outcome in schizophrenia. Archives of General Psychiatry, 30, 429–434.
Strauss, J. S. & Carpenter, W. T. (1977) Prediction of outcome in schizophrenia. Archives of General Psychiatry, 34, 159–163.
van Praag, H. M. (1976) About the impossible concept of schizophrenia. Comprehensive Psychiatry, 17, 481–497.
van Putten, T. & May, P. R. A. (1978) “Akinetic” depression in schizophrenia. Archives of General Psychiatry, 35, 1101–1107.
Vaughn, C. E. & Leff, J. P. (1976) The influence of family and social factors on the course of psychiatric illness. British Journal of Psychiatry, 129, 125–137.
Wing, J. K. (1961) A simple and reliable sub-classification of chronic schizophrenia. Journal of Mental Science, 107, 862–875.
Wing, J. K. & Brown, G. W. (1970) Institutionalism and Schizophrenia. Cambridge: Cambridge University Press.
Wing, J. K.
Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. Cambridge: Cambridge University Press.
Wistedt, B. (1981) A depot neuroleptic withdrawal study. Acta Psychiatrica Scandinavica, 64, 65–84.
World Health Organisation (1973) The International Pilot Study of Schizophrenia. Volume 1
World Health Organisation (1980) Changing Patterns in Mental Health Care. Copenhagen: WHO.